NVJ1 Antibody

What is NVJ1 and why are antibodies against it important for research?

NVJ1 is a yeast protein that forms nucleus-vacuole junctions (NVJs) by tethering between the nuclear envelope and the vacuolar membrane. Antibodies against NVJ1 are essential research tools for studying membrane contact sites, metabolic pathway compartmentalization, and starvation-induced microautophagy of the nucleus. These antibodies enable the detection, localization, and characterization of NVJ1's interactions with other proteins, particularly during metabolic stress conditions such as acute glucose restriction (AGR) .

What cellular processes involve NVJ1 that researchers might investigate using antibodies?

NVJ1 is involved in several critical cellular processes that can be investigated using specific antibodies:

• Formation and maintenance of nucleus-vacuole junctions

• Spatial reorganization of the mevalonate pathway during glucose restriction

• Selective retention of HMG-CoA Reductases (HMGCRs) at the NVJ

• Enhancing mevalonate pathway flux through compartmentalization

• Starvation-induced microautophagy of the nucleus

• Adaptive metabolic remodeling during nutrient stress

• Growth resumption following glucose starvation

How can researchers validate the specificity of NVJ1 antibodies?

Validating NVJ1 antibody specificity requires multiple complementary approaches:

• Comparative immunoblotting using wild-type yeast versus nvj1Δ knockout strains (absence of signal in knockout confirms specificity)

• Pre-absorption controls by incubating the antibody with purified recombinant NVJ1 protein

• Correlation of antibody staining patterns with GFP-tagged NVJ1 localization

• Western blot analysis showing a single band of appropriate molecular weight

• Testing against known NVJ1 mutants (such as F319E or RK→AA mutants) to confirm differential binding patterns

How can researchers use NVJ1 antibodies to study nucleus-vacuole junction dynamics?

For studying NVJ dynamics:

• Perform time-course immunofluorescence microscopy during metabolic transitions

• Combine with fluorescent vacuole markers (e.g., CMAC at 5 μg/mL for two hours) to visualize the junction formation

• Quantify NVJ integrity by measuring the fluorescence intensity ratio between NVJ-associated NVJ1 and non-NVJ nuclear envelope signal

• Use background subtraction with Gaussian blur filtering (sigma radius=5.0) followed by line scan analysis across the nuclear envelope

• Compare wild-type protein distribution with mutant forms (like Nvj1p-EGFP F319E) that show dispersed localization along the nuclear envelope rather than NVJ enrichment

How can NVJ1 antibodies help investigate the compartmentalization of metabolic pathways?

NVJ1 antibodies can reveal mechanisms of metabolic pathway compartmentalization through:

• Co-immunoprecipitation experiments to identify protein complexes at the NVJ

• Dual immunofluorescence with antibodies against HMGCRs and NVJ1 to visualize co-localization

• Correlative light and electron microscopy to examine ultrastructural details of compartmentalized enzyme assemblies

• Proximity labeling approaches using NVJ1 antibodies to identify the complete protein interactome at the NVJ

• Quantitative analysis of protein assemblies during normal growth versus glucose restriction conditions, revealing how NVJ1 promotes the association of HMGCRs into high molecular weight assemblies

What methodological considerations are important when using NVJ1 antibodies in immunofluorescence microscopy?

Critical methodological considerations include:

• Proper fixation: 3-4% formaldehyde for 30 minutes preserves NVJ structure

• Cell wall digestion: Treatment with zymolyase is essential for antibody penetration

• Co-staining: Use DAPI for nuclear visualization and vacuolar membrane markers (e.g., CMAC)

• Background reduction: Convert RGB images to 16-bit and subtract Gaussian-blurred duplicates

• Quantification: Use 5-pixel line scans across the nuclear envelope for plotting fluorescence intensity profiles

• Image acquisition parameters: Must be consistent across experimental conditions for valid comparisons

• Controls: Include both positive (wild-type) and negative (nvj1Δ) samples in each experiment

How do researchers detect protein-protein interactions involving NVJ1?

To detect NVJ1 interactions with proteins like Vac8p:

• Co-immunoprecipitation: Pull down with NVJ1 antibodies followed by immunoblotting for interacting partners

• Yeast two-hybrid assays: Map interaction domains between NVJ1 and binding partners

• Structural studies: The crystal structure of Vac8p-Nvj1p complex at 2.4-Å resolution provides molecular details of the interaction interface

• Mutational analysis: Key residues involved in protein binding can be identified (e.g., F319E mutation reduces affinity for Vac8p)

• In vivo validation: Express mutant forms (such as Nvj1p-EGFP triple mutant) to assess effects on protein localization and function

What is the optimal protein extraction protocol for NVJ1 antibody detection in Western blotting?

The optimal protein extraction protocol includes:

• Collect approximately 50 OD units of cells

• Normalize cell pellet wet weights before extraction

• Precipitate proteins with 20% TCA for 30 minutes on ice

• Wash the pellet three times with cold 100% acetone

• Dry the protein pellet for 15 minutes in a speed-vac

• Resuspend in 2x SDS sample buffer (65.8 mM Tris-HCl pH 6.8, 2% SDS, 25% glycerol, 10% 2-mercaptoethanol, 0.01% bromophenol blue)

• Heat samples at 70°C for 10 minutes prior to loading onto 4-15% polyacrylamide gels

• Transfer to 0.45 μm nitrocellulose membrane using Towbin SDS transfer buffer

What controls should be included when performing Western blotting with NVJ1 antibodies?

Essential controls include:

• Positive control: Wild-type yeast lysate expressing NVJ1

• Negative control: Lysate from nvj1Δ knockout strain

• Loading controls: Tubulin (Abcam ab6160; 1:15,000 dilution) or Sec61 (1:5000 dilution)

• Protein size marker to confirm correct molecular weight

• Secondary antibody-only control to detect non-specific binding

• Ponceau S staining of membrane to confirm equal protein loading and transfer efficiency

• For mutant analysis, include wild-type NVJ1 in parallel for direct comparison

How can researchers perform FRAP and FLIP experiments to study NVJ1 dynamics?

For FRAP and FLIP experiments:

• Grow and collect yeast as described for standard protocols

• Conduct imaging within 1 hour after collection

• Use an Andor spinning disk confocal microscope with a 63x oil objective (NA = 1.4)

• For FRAP, bleach a single circular ROI of 0.77 μm diameter

• For FLIP, continually bleach one region while monitoring fluorescence loss in adjacent areas

• Calculate half-time recovery (for FRAP) or loss (for FLIP)

• Compare dynamics between wild-type and mutant proteins (NVJ1 exhibits selective retention at NVJs with average lifetime >100s compared to ~25s elsewhere on the nuclear envelope)

• Account for potential changes in cytoplasmic viscosity during acute glucose restriction

How can NVJ1 antibodies help study the role of NVJ1 in mevalonate pathway regulation during glucose restriction?

To study NVJ1's role in mevalonate pathway regulation:

• Perform immunoblotting to track NVJ1 expression changes during glucose restriction

• Use co-immunoprecipitation to identify interactions with mevalonate pathway enzymes (HMGCRs)

• Combine with metabolic labeling using 14C-acetate to correlate NVJ1 activity with pathway flux

• Compare wild-type versus nvj1Δ cells for HMG-CoA accumulation and downstream products

• Analyze NVJ1 mutants with intact NVJ formation but defective HMGCR recruitment (e.g., Nvj1 RK→AA)

• Correlate antibody-detected protein levels with functional outcomes such as growth resumption following glucose starvation

How do researchers distinguish between different mutant forms of NVJ1?

To distinguish between NVJ1 mutant forms:

• Use epitope-specific antibodies that can differentiate wild-type from mutant proteins

• Perform immunofluorescence to visualize localization patterns (wild-type Nvj1p-EGFP localizes to NVJs while mutants like F319E show dispersed nuclear envelope localization)

• Analyze protein-protein interactions via co-immunoprecipitation (the triple mutant shows no affinity for Vac8p)

• Combine with functional assays to correlate mutation effects with phenotypic outcomes

• Compare fluorescence intensity profiles across the nuclear envelope for quantitative assessment of localization differences

What techniques can assess NVJ1's role in high molecular weight protein assemblies?

To assess NVJ1's role in protein assemblies:

• Use size exclusion chromatography followed by immunoblotting with NVJ1 antibodies

• Perform sucrose gradient ultracentrifugation to separate protein complexes by size

• Employ blue native PAGE to preserve protein complexes during electrophoresis

• Compare assembly formation between wild-type and mutant proteins

• Correlate with functional studies (e.g., artificial multimerization of Hmg1 using DsRed2 tagging can bypass the requirement for NVJ1-mediated compartmentalization)

• Combine with metabolic flux analysis using 14C-acetate to connect assembly formation with pathway activity

How should researchers quantify NVJ1 antibody signals in microscopy experiments?

For quantitative analysis of NVJ1 signals:

• Convert RGB images to 16-bit format

• Perform background subtraction by subtracting original images by a duplicate 'Gaussian blur' filtered image (sigma radius = 5.0)

• Take five-pixel line scans across the nuclear envelope toward the NVJ

• Use the 'plot profile' function in Fiji to produce fluorescence histograms

• Calculate the ratio of fluorescence intensity at NVJ-associated regions versus non-NVJ nuclear envelope signal

• Establish consistent thresholds for defining NVJ regions

• Analyze multiple cells (n>30) per condition for statistical robustness

How can researchers interpret contradictory results between antibody-based detection and fluorescent protein tagging approaches?

When facing contradictory results:

• Consider tag-induced artifacts: Some tags (like DsRed2) can cause artificial multimerization while others (mRuby3) do not

• Validate with multiple detection methods: Compare antibody staining with different fluorescent protein fusions

• Check expression levels: Ensure comparable protein expression across different constructs

• Perform functional assays: Correlate localization with functional outcomes (e.g., mevalonate pathway flux)

• Use complementary approaches: Combine biochemical fractionation with microscopy

• Consider cell-to-cell variability: Quantify population distributions rather than averaging signals

• Test multiple antibodies: Different epitopes may be differentially accessible in protein complexes

How can researchers correlate NVJ1 antibody data with physiological outcomes?

To correlate antibody data with physiological outcomes:

• Perform growth assays following glucose starvation (10 hours in SC media lacking glucose)

• Measure mevalonate pathway flux using 14C-acetate pulse-radiolabeling

• Quantify metabolites like HMG-CoA, squalene, ergosterol, and sterol-esters

• Track cell growth resumption timing after nutrient stress

• Compare wild-type, nvj1Δ, and specific mutant phenotypes (Nvj1 RK→AA)

• Correlate antibody-detected NVJ1 localization patterns with growth phenotypes

• Assess the ability of artificial multimerization (Hmg1-DsRed2) to rescue growth defects in nvj1Δ strains